In order to implement the “Cosmetics Supervision and Administration Regulations”, “Cosmetics Production and Operation Supervision and Administration Measures”, and “Cosmetics Adverse Reaction Monitoring and Management Measures”, to strengthen the monitoring of cosmetic adverse reactions, and improve cosmetics, the National Medical Products Administration (National Medical Products Administration) has organized the upgrade and improvement of the national cosmetic adverse reaction monitoring system. The new version of the system will be launched on October 1, 2022.
Relevant matters are hereby notified as follows:
1. From October 1, 2022, cosmetic registrants, filing person, entrusted manufacturers, cosmetic operators, and medical institutions shall report the adverse cosmetic reactions through the national cosmetic adverse reactions Monitoring system reports. Cosmetics operators and medical institutions that do not have the conditions for online reporting for the time being should report to the local city and county-level cosmetic adverse reaction monitoring agencies through paper statements, which will submit reports online on their behalf. Other units and individuals may report adverse reactions of cosmetics to the cosmetics registrant, filing person, and domestic responsible person, or to the monitoring agency for adverse reactions of cosmetics at the city or county level or the department responsible for drug supervision and management at the city or county level.
2. Newly registered users of the National Cosmetic Adverse Reaction Monitoring System should click on “Registration of Primary Institutions” on the system login page (https://caers.adrs.org.cn/adrcos/) to submit a registration application and fill in the relevant information. After approval, the registered users of the system can use their account and password to log in to the system and report adverse reactions to cosmetics. Previously registered users of the system can continue to use their original account and password to log in to the system at the above website and report adverse cosmetic reactions.
3. After the registered users log in to the system, they can view the “System User Operation Manual” and “System Operation Video” on the “Welcome” page of the system.
National Medical Products Administration
Source: NMPA